Atlas Trials

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Clinical trial NCT06722157 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06722157
Sponsor
Boehringer Ingelheim
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Macular Degeneration, Age-relatedGeographic Atrophy
Start date
2025-01-06
Primary completion
2026-10-28
Enrollment
202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.